Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8035)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2019 (publication date) through Jul 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wan XB, Wang AQ, Cao J, Dong ZC, Li N, Yang S, Sun MM, Li Z, Luo SX. Relationships among KRAS mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer. World J Gastroenterol 2019; 25(7): 808-823 [PMID: 30809081 DOI: 10.3748/wjg.v25.i7.808] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i7/808.htm |
| Number | Citing Articles |
| 1 |
Wei Song, Jun Ren, Wen-Jie Wang, Chun-Tao Wang, Tao Fu. Genome-wide Methylation and Expression Profiling Identify a Novel Epigenetic Signature in Gastrointestinal Pan-Adenocarcinomas. Epigenomics 2020; 12(11): 907 doi: 10.2217/epi-2020-0036
|
| 2 |
Tarun Rajpurohit, Sankha Bhattacharya. Moving Towards Dawn: KRas Signaling and Treatment in Pancreatic
Ductal Adenocarcinoma. Current Molecular Pharmacology 2022; 15(7): 904 doi: 10.2174/1874467215666220128161647
|
| 3 |
Tian Fang, Tingting Liang, Yizhuo Wang, Haitao Wu, Shuhan Liu, Linying Xie, Zhihao Zhang, Jiaying Liang, Cheng Yao, Yehui Tan, Chang Wang. An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.755578
|
| 4 |
Dorte Aa. Olsen, Caroline E. B. Thomsen, Rikke F. Andersen, Jonna S. Madsen, Anders Jakobsen, Ivan Brandslund. Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77109-8
|
| 5 |
Jiyan Wang, Hongkai Chang, Meng Su, Huifang Zhao, Yaya Qiao, Yu Wang, Luqing Shang, Changliang Shan, Shuai Zhang. The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.934729
|
| 6 |
Kiran Tripathi, Niharika Maurya, Apul Goel, Atin Singhai, Minal Garg. Immunohistochemical expressions of EMT markers in pan-RAS–pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients. Molecular and Cellular Biochemistry 2023; 478(6): 1169 doi: 10.1007/s11010-022-04579-x
|
| 7 |
Shaoqiang Zhou, Ding Zhang, Junjie Li, Jing Zhao, Guoqiang Wang, Yuzi Zhang, Yuezong Bai, Dedian Chen, Hao Wu. Landscape of RAS Variations in 17,993 Pan-cancer Patients Identified by Next-generation Sequencing. Pathology & Oncology Research 2020; 26(4): 2835 doi: 10.1007/s12253-020-00845-9
|
| 8 |
Shiva Kamran, Ensiyeh Seyedrezazadeh, Dariush Shanehbandi, Milad Asadi, Venus Zafari, Najibeh Shekari, Leila Namvar, Habib Zarredar. Combination Therapy with KRAS and P38α siRNA Suppresses Colorectal Cancer Growth and Development in SW480 Cell Line. Journal of Gastrointestinal Cancer 2022; 53(3): 597 doi: 10.1007/s12029-021-00667-1
|
| 9 |
Haiqi Liang, Guiyou Zhou, Lianhua Lv, Jiarong Lu, Jiashun Peng. KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer. Breast Cancer 2021; 28(2): 379 doi: 10.1007/s12282-020-01170-4
|
| 10 |
Yebohao Zhou, Ziwei Zeng, Ze Li, Lei Ruan, Hao Xie, Fujin Ye, Liang Huang, Huashan Liu, Liang Kang. The relationship of KRAS expression with KRAS status, prognosis, and tumor-infiltrated T lymphocytes in colorectal cancer. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241249387
|
| 11 |
Xiaojue Zhu, Yonghao Li, Guoxin Xu, ChangQing Fu. Growth hormone receptor promotes breast cancer progression via the BRAF/MEK/ERK signaling pathway. FEBS Open Bio 2020; 10(6): 1013 doi: 10.1002/2211-5463.12816
|
| 12 |
Maysaa Ghazi Jumaa. PATTERN OF KRAS GENE EXPRESSION IN IRAQI WOMEN OVARIAN CARCINOMA. Wiadomości Lekarskie 2022; 75(4): 765 doi: 10.36740/WLek202204103
|
| 13 |
Danyang Wang, Qingmin Liu, Yanjun Ren, Yan Zhang, Xin Wang, Bing Liu. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival. Bioscience Reports 2021; 41(4) doi: 10.1042/BSR20204136
|
| 14 |
Shodai Mizuno, Ryo Seishima, Juntaro Yamasaki, Kaoru Hattori, Masayo Ogiri, Shimpei Matsui, Kohei Shigeta, Koji Okabayashi, Osamu Nagano, Liang Li, Yuko Kitagawa. Angiopoietin-like 4 promotes glucose metabolism by regulating glucose transporter expression in colorectal cancer. Journal of Cancer Research and Clinical Oncology 2022; 148(6): 1351 doi: 10.1007/s00432-022-03960-z
|
| 15 |
Yu-hu Huo, Ya-ni Wang, Ling-bing Meng, Ai-li Zhang, Bin Liu. Progress in the correlation between PTPN12 gene expression and human tumors. Medicine 2020; 99(24): e20445 doi: 10.1097/MD.0000000000020445
|
| 16 |
Zhenlin Wang, Mengchen Yin, Peilin Chu, Meiqing Lou. STAT3 inhibitor sensitized KRAS-mutant lung cancers to RAF inhibitor by activating MEK/ERK signaling pathway. Aging 2019; 11(17): 7187 doi: 10.18632/aging.102244
|
| 17 |
Suhyeon Park, Yumin Kim, Jibeom Lee, Jeong Yun Lee, Hail Kim, Sunjae Lee, Chang-Myung Oh. A Systems Biology Approach to Investigating the Interaction between Serotonin Synthesis by Tryptophan Hydroxylase and the Metabolic Homeostasis. International Journal of Molecular Sciences 2021; 22(5): 2452 doi: 10.3390/ijms22052452
|
| 18 |
Yang Xi, Pan Yuefen, Wu Wei, Qi Quan, Zhuang Jing, Xu Jiamin, Han Shuwen. Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-2102-1
|
| 19 |
Si Wang, Rui-Ze Sun, Qiang Han, Si-Yao Wang, En-Hua Wang, Yang Liu. Genomic Study of Chinese Quadruple-negative GISTs Using Next-generation Sequencing Technology. Applied Immunohistochemistry & Molecular Morphology 2021; 29(1): 34 doi: 10.1097/PAI.0000000000000842
|
| 20 |
Kyu‐Young Oh, Ji‐Hoon Kim, Sung‐Dae Cho, Hye‐Jung Yoon, Jae‐Il Lee, Seong‐Doo Hong. BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type. Genes, Chromosomes and Cancer 2022; 61(8): 481 doi: 10.1002/gcc.23040
|
| 21 |
Bo Ban, An Shang, Jian Shi. Development and validation of a nomogram for predicting metachronous peritoneal metastasis in colorectal cancer: A retrospective study. World Journal of Gastrointestinal Oncology 2023; 15(1): 112-127 doi: 10.4251/wjgo.v15.i1.112
|
| 22 |
Zhaokai Zhou, Ting Lin, Shuang Chen, Ge Zhang, Yudi Xu, Haijiao Zou, Aoyang Zhou, Yuyuan Zhang, Siyuan Weng, Xinwei Han, Zaoqu Liu. Omics-based molecular classifications empowering in precision oncology. Cellular Oncology 2024; 47(3): 759 doi: 10.1007/s13402-023-00912-8
|
| 23 |
Atena Soleimani, Farzad Rahmani, Nikoo Saeedi, Rana Ghaffarian, Majid Khazaei, Gordon A. Ferns, Amir Avan, Seyed Mahdi Hassanian. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer. Journal of Cellular Biochemistry 2019; 120(12): 19245 doi: 10.1002/jcb.29268
|
| 24 |
Hong-Min Ahn, Duck-Woo Kim, Hyeon Jeong Oh, Hyung Kyung Kim, Hye Seung Lee, Tae Gyun Lee, Hye-Rim Shin, In Jun Yang, Jeehye Lee, Jung Wook Suh, Heung-Kwon Oh, Sung-Bum Kang. Different oncological features of colorectal cancer codon-specific <i>KRAS</i> mutations: Not codon 13 but codon 12 have prognostic value. World Journal of Gastroenterology 2023; 29(32): 4883-4899 doi: 10.3748/wjg.v29.i32.4883
Abstract(391) |
Core Tip(466) |
Full Article(HTML)(1772)
|
Full Article with Cover (PDF)-1902K(54)
|
Full Article (Word)-766K(36)
|
Audio-839K(4)
|
Peer-Review Report-389K(39)
|
Answering Reviewers-521K(36)
|
Full Article (PDF)-1656K(141)
|
Full Article (XML)-188K(41)
|
Times Cited (3)
|
Total Visits (5400)
|
Open
|
| 25 |
Karolina Juszczyk, Mohamed Zaafer Afzal, Timothy Ganguly, Thu‐Lan Kelly, Robyn Zeelie, Elizabeth Mary Ann Murphy. Evaluating whether KRAS/BRAF mutation status, anaemia and obstruction are associated with recurrence and mortality in non‐metastatic colorectal cancer. ANZ Journal of Surgery 2023; 93(10): 2457 doi: 10.1111/ans.18470
|